GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sunrest Lifescience SUNREST.NS · INR

N/A · NSE · 🇮🇳 India

Compare

35.50

—

Close of 4 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹334.1m

FY2021FY2025

Net income

₹20.1m

FY2021FY2025

Free cash flow

₹15.5m

FY2021FY2025

Shareholders' equity

₹163.1m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Revenue₹334.1m₹294.8m₹246.4m₹268.9m₹169.5m
Gross profit₹133.4m₹95.0m₹97.6m₹94.3m₹56.0m
Operating income₹29.2m₹8.1m₹27.7m₹10.4m₹2.3m
Net income₹20.1m₹2.3m₹20.4m₹7.8m₹1.7m
Diluted earnings per share4.670.684.761.810.39

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assets₹586.5m₹251.6m₹167.1m₹130.2m₹94.8m
Cash and short-term investments₹17.4m₹2.9m₹4.5m₹4.8m₹3.7m
Total liabilities₹423.4m₹109.7m₹136.0m₹119.5m₹91.9m
Debt₹120.5m₹61.6m₹21.4m₹32.4m₹23.2m
Shareholders' equity₹163.1m₹141.9m₹31.2m₹10.7m₹2.9m
Shares outstanding4m3m4m4m4m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations₹29.2m−₹148.0m₹11.6m−₹4.5m₹1.5m
Capital spending−₹13.7m−₹71,000−₹140,000−₹4.7m−₹1.6m
Free cash flow₹15.5m−₹148.0m₹11.4m−₹9.2m−₹80,000

Latest quarters

By quarter end

Mar 2025Sept 2024Mar 2024Sept 2023Jun 2023
Revenue₹180.2m₹153.9m₹294.8m₹68.4m₹56.4m
Gross profit₹65.6m₹67.7m₹95.0m₹24.6m₹34.5m
Operating income₹20.3m₹8.9m₹8.1m₹6.3m₹9.8m
Net income₹14.2m₹5.8m₹2.3m₹12.3m₹7.5m
Diluted earnings per share3.322.710.687.231.75
Total assets₹586.5m₹271.5m₹251.6m—₹170.6m
Cash and short-term investments₹17.4m₹3.0m₹2.9m—₹6.1m
Debt₹120.5m₹54.5m₹34.6m—₹33.3m
Shareholders' equity₹163.1m₹147.7m₹141.9m—₹38.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.5%——
Operating income41.1%——
Net income37.0%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.3%36.7%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings9.275.713.4
Price to sales0.60.61.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.